Dr. Joseph Geraci wins the Scientific Poster Award for the NetraAI technology for the personalization of Alzheimer’s Disease

April 25, 2018


Here one can access our Whitepaper which reviews the state of drug development and how NetraMark is providing next generation machine learning methods to disrupt this industry. We review patient stratification, deep phenotyping, drug repositioning, and placebo response and how we are addressing these challenges.